Google Übersetzer
Aclaris Therapeutics, Inc.
About
Aclaris Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indicati...
Apr 27 2026
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
Apr 8 2026
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
Mar 27 2026
Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138
Mar 20 2026
Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Recent Videos
Cómo invertir en Aclaris Therapeutics Inc (ACRS) paso a paso
Mar 22, 2026
ACRS STOCK : BIG PRICE RECOVERY | ACLARIS THERAPEUTICS STOCK
Feb 20, 2026
STRONG MOMENTUM | ACRS STOCK ANALYSIS | ACLARIS THERAPEUTICS STOCK
Jan 22, 2026
BIOTECH | Why #CRVS, #ACRS, and #RAPT Exploded Today (Jan 20, 2026) #Biotech
Jan 21, 2026